Taro Pharmaceutical Industries Ltd. Provides 2011 Third Quarter and Year to Date Results

HAWTHORNE, N.Y.--(BUSINESS WIRE)--Taro Pharmaceutical Industries Ltd. (“Taro,” or the “Company,” Pink Sheets: TAROF) today provided unaudited financial results for the quarter and year to date periods ended September 30, 2011.

Third Quarter 2011 Highlights vs. 2010

•Net sales of $138.3 million, increased $35.2 million or 34.1%, •Gross profit, as a percentage of net sales was 67.5%, compared to 60.1%

Back to news